Astria Therapeutics (ATXS) Q2 2023 Earnings

7AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.92
-0.75
-0.57
-0.4

Details

Expected EPS
-0.49
Actual EPS
-0.45
Surprise EPS
0.04
Surprise Percent
+8.16%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.45 per share for Q2 2023.

0 Comments

Share your thoughts